Seres Therapeutics (Germany) Probability of Future Stock Price Finishing Over 8.65
| 1S9 Stock | EUR 0.84 0.01 1.20% |
Seres |
Seres Therapeutics Target Price Odds to finish over 8.65
The tendency of Seres Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 8.65 or more in 90 days |
| 0.84 | 90 days | 8.65 | close to zero percent |
Based on a normal probability distribution, the odds of Seres Therapeutics to move over € 8.65 or more in 90 days from now is close to zero percent (This Seres Therapeutics probability density function shows the probability of Seres Stock to fall within a particular range of prices over 90 days) . Probability of Seres Therapeutics price to stay between its current price of € 0.84 and € 8.65 at the end of the 90-day period is about 26.23 .
Assuming the 90 days horizon Seres Therapeutics has a beta of 0.79. This suggests as returns on the market go up, Seres Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Seres Therapeutics will be expected to be much smaller as well. Additionally Seres Therapeutics has an alpha of 0.0036, implying that it can generate a 0.003612 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Seres Therapeutics Price Density |
| Price |
Predictive Modules for Seres Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Seres Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Seres Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Seres Therapeutics is not an exception. The market had few large corrections towards the Seres Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Seres Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Seres Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0 | |
β | Beta against Dow Jones | 0.79 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | -0.0022 |
Seres Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Seres Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Seres Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Seres Therapeutics had very high historical volatility over the last 90 days | |
| Seres Therapeutics has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 144.93 M. Net Loss for the year was (65.58 M) with profit before overhead, payroll, taxes, and interest of 3.04 M. | |
| Over 86.0% of the company shares are owned by institutions such as pension funds |
Seres Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Seres Stock often depends not only on the future outlook of the current and potential Seres Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Seres Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 91.9 M |
Seres Therapeutics Technical Analysis
Seres Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Seres Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Seres Therapeutics. In general, you should focus on analyzing Seres Stock price patterns and their correlations with different microeconomic environments and drivers.
Seres Therapeutics Predictive Forecast Models
Seres Therapeutics' time-series forecasting models is one of many Seres Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Seres Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Seres Therapeutics
Checking the ongoing alerts about Seres Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Seres Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Seres Therapeutics had very high historical volatility over the last 90 days | |
| Seres Therapeutics has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 144.93 M. Net Loss for the year was (65.58 M) with profit before overhead, payroll, taxes, and interest of 3.04 M. | |
| Over 86.0% of the company shares are owned by institutions such as pension funds |
Additional Information and Resources on Investing in Seres Stock
When determining whether Seres Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Seres Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Seres Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Seres Therapeutics Stock:Check out Seres Therapeutics Backtesting, Seres Therapeutics Valuation, Seres Therapeutics Correlation, Seres Therapeutics Hype Analysis, Seres Therapeutics Volatility, Seres Therapeutics History as well as Seres Therapeutics Performance. For more detail on how to invest in Seres Stock please use our How to Invest in Seres Therapeutics guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.